Clinical Trial: Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma
Study Status: Completed
Recruit Status: RECRUITING
Condition: Refractory Non-Hodgkin Lymphoma
Study Type: INTERVENTIONAL
Official Title: Phase 1, Open-Label Study of Autologous SIRP?-low Macrophages (SIRPant-M) Administered by Intratumoral Injection Alone or in Combination With Focal External-Beam Radiotherapy in Participants With Rela
Brief Summary:
The goal of this study is to test SIRPant-M, an autologous cell therapy, alone or in combination with focal external-beam radiotherapy in participants with relapsed or refractory non-Hodgkin's lymphoma (NHL).Two dose levels of SIRPant-M are being tested.The main question this study aims to answer is if SIRPant-M alone or in combination with radiotherapy is safe and well-tolerated.
Read more